The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title Announcement Number
Activity Code
Clinical Trials Status Expiration Date
Sort descending
Program Official
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute NOT-CA-23-035
11/13/2024
Jessica Faupel-Badger, Ph.D., M.P.H.
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment RFA-NS-22-034 (R01 Clinical Trial Not Allowed)
R01
Clinical Trial Not Allowed
12/07/2024
Rachel Altshuler, Ph.D.
Notice of Intent to Publish a Funding Opportunity Announcement for Consortium for Palliative Care Research Across the Lifespan NOT-AG-23-050 (U54 Clinical Trial Required)
U54
Clinical Trial Required
12/31/2024
Brennan Streck, Ph.D., R.N., M.P.H.
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities PAR-22-064 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
01/08/2025
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer PAR-22-061 (R01 Clinical Trial Not Allowed)
R01
Clinical Trial Not Allowed
01/08/2025
Young Kim, Ph.D.
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PAR-22-114
Clinical Trial Optional
01/24/2025
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional)
R01
Clinical Trial Optional
02/07/2025
Rachel Altshuler, Ph.D.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) NOT-OD-22-202
Clinical Trial Not Allowed
04/16/2025
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-173 (R34 Clinical Trials Optional)
R34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-174 (U34 Clinical Trials Optional)
U34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
